Laxmi Dental share price, P/E, ROE & financials

Laxmi Dental (LAXMIDENTL) had a P/E of 34.8× on 6 Nov 2026, above the industry P/E of 28.6×, and the shares are 43% below their 52-week high. It earns ROCE of 11% and ROE of 13%, and sales grew 20% a year over 3 years. The company has almost no debt. It is a small-cap company with a market cap of ₹1,081 Cr, ranked 5th of 11 Medical Instruments & Supplies companies by market cap; the shares fell 38% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹194.00
Day high: ₹198.01
Day low: ₹188.00
Prev. close: ₹196.51
Volume: 1.6 L

Health check

1 good · 2 fair · 3 to check

ReturnsBehind
−37.9% over a year, better than 1 of 7 peers.
Price tagPricier
P/E 34.8 vs industry 28.6.
GrowthStrong
Sales +19.5% a year over 3 years.
ProfitabilityAverage
ROCE 11.5% vs peer median 13.3%.
Balance sheetFair
Debt 0.05× equity, interest covered 23.1×, Piotroski 4 of 9.
Red flags1 to check
43% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Instruments & Supplies

10 listed peers. Screen the industry

Small cap

₹1,081 Cr, #5 of 11 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹287 Cr · profit ₹31 Cr

Market cap: ₹1,081 Cr; Small cap
P/E: 34.8; Industry 28.6
Price to book: 4.44; Peers 5.26
Dividend yield: 0.00%
ROE: 12.8%; Peers 10.5%
ROCE: 11.5%; Peers 13.3%
Debt to equity: 0.05; Debt ₹13 Cr
EPS (TTM): ₹5.64; Face value ₹2
OPM (TTM): 15.0%; Net margin 10.8%
Sales growth: +13.5%; Latest quarter vs a year ago
Profit growth: +22.8%; Latest quarter vs a year ago
Price to sales: 3.77; EV/EBITDA 21.2

Strengths

Practically debt-free.
Quarterly profit up 22.8% on a year ago.

Risks to check

43% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Laxmi Dental

Laxmi Dental Limited manufactures and sells dental products in India, the United States, the United Kingdom, and internationally. The company provides custom-made crowns, bridges, clear aligners, thermoforming sheets, aligner related products, and pediatric dental products. It serves dental clinics, dental companies, and dentist. The company was incorporated in 2004 and is based in Mumbai, India.

Headquarters: Mumbai
Employees: 2,513
Sector: Healthcare
ISIN: INE0WO601020
Website: laxmidentallimited.com

Price range

52 weeks

₹155.88₹344.80

Today

₹188.00₹198.01

Avg volume (3M): 95.8K
1-year return: minus 37.9%
From 52-week high: minus 43.0%

Peers · Medical Instruments & Supplies

Compare with peers Screen the whole industry

Company
LENSKARTLenskart Solutions	724.75	plus 0.89%	1,25,562	160.7	13.48	7.2%	6.7%	20.8%	–	–	0.00%	plus 79.8%
AGARWALEYEDr. Agarwal's Health Care	516.35	plus 0.91%	16,373	94.1	7.66	9.7%	6.8%	15.0%	26.9%	12.3%	0.00%	minus 0.7%
POLYMEDPoly Medicure	1,612.30	plus 0.63%	16,343	51.4	5.26	13.3%	11.0%	15.2%	18.8%	21.6%	0.22%	minus 18.1%
TARSONSTarsons Products	316.95	minus 0.46%	1,686	151.7	2.64	4.8%	2.3%	−0.9%	14.3%	−43.8%	0.00%	plus 10.9%
LAXMIDENTLLaxmi Dental	196.42	minus 0.05%	1,081	34.8	4.44	11.5%	12.8%	16.4%	19.5%	–	0.00%	minus 37.9%
PREVESTPrevest Denpro	397.85	minus 3.85%	478	22.0	3.83	21.9%	17.8%	34.8%	12.4%	9.3%	0.25%	minus 21.2%
QMSMEDIQMS Medical Allied Services	168.66	minus 0.69%	326	28.6	5.68	18.4%	10.5%	12.0%	18.4%	16.7%	0.30%	plus 75.0%
SHREEPACShree Pacetronix	170.00	plus 0.32%	64	19.5	3.41	25.0%	19.7%	24.8%	2.2%	−1.2%	0.00%	minus 38.5%
Median of 7 peers	–	0.32%	1,686	51.4	5.26	13.3%	10.5%	15.2%	16.4%	10.8%	0.00%	−0.7%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
64.3	71	64	72.2	73
52.4	60	60.8	58.7	58.6
11.9	11	3.3	13.5	14.4
18.5%	15.5%	5.1%	18.7%	19.7%
1.7	2.4	5.8	2.4	2.3
0.5	0.2	0.3	0.3	0.3
3.6	3.7	4.2	4.4	4.3
–	–	−5.8	–	–
9.6	9.4	−1.2	11.1	12
23.8%	19.8%	175.6%	4.5%	20.7%
8.4	8.5	2	10.1	10.3
1.52	1.58	0.36	1.83	1.87

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +19.5%
ROE: 12.8%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
159	191	237	272
–	+20.5%	+23.6%	+14.8%
149	166	193	227
9.9	25.4	43.3	44.4
6.3%	13.2%	18.3%	16.4%
1.3	0.5	2.1	7.6
4.1	5	5.4	1.3
11	11.9	15	15.9
−0.4	−0.5	6.8	−5.9
−4.3	8.5	31.8	28.9
−4.4%	−110.5%	20.3%	8.6%
−4	24.8	31.8	29
–	–	+28.2%	minus 8.8%
-0.72	4.51	6.05	5.26

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
11.9	11.9	11	11
−5.8	18.9	198	232
38.7	49.8	19.5	13
51.7	53.9	56.6	37.6
96.5	135	285	294
38.2	43.6	48.9	59.2
1.3	1.3	24.3	12.1
1.6	1	109	86.4
55.5	88.6	102	136
96.5	135	285	294

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
14.4	8.2	43.8	−5
−9.4	−10.8	−29.2	−79.6
−1.5	−2.7	111	−17.8
3.6	−5.3	125	−102
−10	−14.8	−16.1	−18.4
4.5	−6.6	27.8	−23.4

Shareholding pattern

Source: NSE filings

41.8%

promoters

Promoters41.75%
Public58.25%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	41.75%	58.25%	minus 0.05
30 Jun 2026	41.80%	58.20%	plus 0.03
31 Mar 2026	41.77%	58.23%	plus 0.07
31 Dec 2025	41.70%	58.30%	0.00
30 Sep 2025	41.70%	58.30%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you